Visual acuity · people with traumatic hyphema
Non‐pharmaceutical interventions showed no clear difference in short‐term visual acuity between 20/20 and 20/60 at end of… compared with control (low certainty).
2 findings from 1 review
Final visual acuity between 20/20 and 20/50; monocular vs binocular eye patching · people with traumatic hyphema
Non‐pharmaceutical interventions showed no clear difference in final visual acuity between 20/20 and 20/50; monocular vs binocular… compared with control (low certainty).
1 finding from 1 review
Time to resolution of primary hemorrhage · people with traumatic hyphema
1 finding from 1 review
Risk of secondary hemorrhage; monocular versus binocular eye patching · people with traumatic hyphema
Non‐pharmaceutical interventions showed no clear difference in risk of secondary hemorrhage; monocular vs binocular eye patching compared with control (low certainty).
1 finding from 1 review
Risk of secondary hemorrhage; ambulatory treatment versus bed rest · people with traumatic hyphema
Non‐pharmaceutical interventions showed no clear difference in risk of secondary hemorrhage; ambulatory treatment vs bed rest compared with control (low certainty).
1 finding from 1 review
Incremental cost‐effectiveness · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
1 finding from 1 review
Proportion of participants requiring further IOP‐lowering interventions (additional surgery, medications, or both) (lower number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
It is very uncertain whether phacoemulsification changes proportion of participants requiring further IOP‐lowering… compared with laser peripheral iridotomy (very low certainty).
1 finding from 1 review
Costs · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Further surgical or laser interventions · adults with PACS or PAC, and previous PI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Further surgical or laser interventions · adults with PAC or PACG, and previous PI
1 finding from 1 review
Intervention not reported
Further surgical or laser interventions · adults with PACS, PAC or PACG
1 finding from 1 review
Economic costs and benefits of different interventions · adult participants with chronic blepharitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of interventions needed to achieve final anatomical success at final · people with simple rhegmatogenous retinal detachments
1 finding from 1 review
Proportion of participants with adverse events with a probable causal link with the study interventions at six months · adults undergoing cataract surgery with IOL implantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Interventions · participants undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Visual acuity · people with traumatic hyphema
Other pharmaceutical agents showed no clear difference in short‐term visual acuity between 20/20 and 20/60 at end of… compared with placebo or other control interventions (low certainty).
1 finding from 1 review
Risk of secondary hemorrhage; conjugated estrogen · people with traumatic hyphema
Other pharmaceutical agents showed no clear difference in risk of secondary hemorrhage; conjugated estrogen compared with placebo or other control interventions (moderate certainty).
1 finding from 1 review
Risk of secondary hemorrhage; cycloplegics · people with traumatic hyphema
It is very uncertain whether other pharmaceutical agents changes risk of secondary hemorrhage; cycloplegics compared with placebo or other control interventions (very low certainty).
1 finding from 1 review
Risk of secondary hemorrhage; aspirin · people with traumatic hyphema
Other pharmaceutical agents showed no clear difference in risk of secondary hemorrhage; aspirin compared with placebo or other control interventions (low certainty).
1 finding from 1 review
Intervention not reported
High‐dose atropine (≥ 0.5%) · children with progressive myopia (38 studies, 6525 participants in analyses) Interventions: optical and pharmacological Comparator:…
1 finding from 1 review